Serbia vs Singapore: Previously treated cases tested for RR-/MDR-TB
Serbia
48.0%
in 2024
Singapore
49.0%
in 2024
Serbia rank
153rd
Singapore rank
151st
Previously treated cases tested for RR-/MDR-TB over time
- Serbia
- Singapore
How they compare
Singapore currently reports 49.0% against 48.0% in Serbia, a difference of 1.0%.
Across all 17 years both countries report, Singapore has been ahead every year.
Serbia ranks 153rd and Singapore ranks 151st of 180 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Serbia | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.8% | 67.2% | 20.5% | Singapore |
| 2010s | 45.4% | 68.5% | 23.1% | Singapore |
| 2020s | 33.7% | 56.3% | 22.7% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Serbia or Singapore?
- Singapore, at 49.0% against 48.0% in Serbia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Serbia and Singapore?
- 1.0%, with Singapore ahead.
- How many years of comparable data are there for Serbia and Singapore?
- 17 years are reported by both, from 2005 to 2024.
- How do Serbia and Singapore rank globally for previously treated cases tested for rr-/mdr-tb?
- Serbia ranks 153rd and Singapore ranks 151st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.